MS therapies: longer-term results

 

REPORT FROM THE 67TH AMERICAN ACADEMY OF NEUROLOGY (AAN) ANNUAL MEETING – WASHINGTON DC, APRIL 18-25, 2015 – A number of new studies at AAN 2015 presented longer-term data on the use of second-generation disease-modifying therapies for MS. The following is a summary of key studies:

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page